These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 15933214)

  • 1. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
    McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective recovery of striatal 125I-alpha-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys.
    Lai A; Sum J; Fan H; McIntosh JM; Quik M
    Neuroscience; 2004; 127(2):399-408. PubMed ID: 15262330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.
    Quik M; Polonskaya Y; Kulak JM; McIntosh JM
    J Neurosci; 2001 Aug; 21(15):5494-500. PubMed ID: 11466420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
    Quik M; Sum JD; Whiteaker P; McCallum SE; Marks MJ; Musachio J; McIntosh JM; Collins AC; Grady SR
    Mol Pharmacol; 2003 May; 63(5):1169-79. PubMed ID: 12695545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.
    O'Leary K; Parameswaran N; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2008 May; 325(2):646-54. PubMed ID: 18305015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
    Kulak JM; McIntosh JM; Quik M
    Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine.
    Bordia T; Parameswaran N; Fan H; Langston JW; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2006 Oct; 319(1):285-92. PubMed ID: 16837557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage.
    Quik M; Polonskaya Y; McIntosh JM; Kulak JM
    Neuroscience; 2002; 112(3):619-30. PubMed ID: 12074903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.
    Quik M; McIntosh JM
    J Pharmacol Exp Ther; 2006 Feb; 316(2):481-9. PubMed ID: 16210393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment.
    McCallum SE; Parameswaran N; Bordia T; Fan H; Tyndale RF; Langston JW; McIntosh JM; Quik M
    J Neurochem; 2006 Feb; 96(4):1028-41. PubMed ID: 16412091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
    Quik M; Vailati S; Bordia T; Kulak JM; Fan H; McIntosh JM; Clementi F; Gotti C
    Mol Pharmacol; 2005 Jan; 67(1):32-41. PubMed ID: 15470079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior.
    Soll LG; Grady SR; Salminen O; Marks MJ; Tapper AR
    Neuropharmacology; 2013 Oct; 73():19-30. PubMed ID: 23688922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration.
    Quik M; Polonskaya Y; Gillespie A; K Lloyd G; Langston JW
    Neuroscience; 2000; 100(1):63-72. PubMed ID: 10996459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
    Quik M; Chen L; Parameswaran N; Xie X; Langston JW; McCallum SE
    J Neurosci; 2006 Apr; 26(17):4681-9. PubMed ID: 16641249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum.
    Bordia T; Grady SR; McIntosh JM; Quik M
    Mol Pharmacol; 2007 Jul; 72(1):52-61. PubMed ID: 17409284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
    Bohr IJ; Ray MA; McIntosh JM; Chalon S; Guilloteau D; McKeith IG; Perry RH; Clementi F; Perry EK; Court JA; Piggott MA
    Exp Neurol; 2005 Feb; 191(2):292-300. PubMed ID: 15649484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of novel alpha-conotoxins on nicotine-stimulated [3H]dopamine release from rat striatal synaptosomes.
    Azam L; McIntosh JM
    J Pharmacol Exp Ther; 2005 Jan; 312(1):231-7. PubMed ID: 15316087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.
    Huang LZ; Parameswaran N; Bordia T; Michael McIntosh J; Quik M
    J Neurochem; 2009 May; 109(3):826-37. PubMed ID: 19250334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-DOPA treatment modulates nicotinic receptors in monkey striatum.
    Quik M; Bordia T; Okihara M; Fan H; Marks MJ; McIntosh JM; Whiteaker P
    Mol Pharmacol; 2003 Sep; 64(3):619-28. PubMed ID: 12920198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.